NeuBase Therapeutics, Inc. - FORM 10-K - EX-23 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - December 14, 2015

Attached files

file filename
EX-14 - CODE OF ETHICS - NeuBase Therapeutics, Inc.ex14.htm
EX-21 - LIST OF SUBSIDIARIES OF OHR PHARMACEUTICAL. INC. - NeuBase Therapeutics, Inc.ex21.htm
EX-31.2 - CHIEF FINANCIAL OFFICER AND PRINCIPAL ACCOUNTING OFFICER - NeuBase Therapeutics, Inc.ex31-2.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - NeuBase Therapeutics, Inc.ex32-1.htm
EX-32.2 - CHIEF FINANCIAL OFFICER AND PRINCIPAL ACCOUNTING OFFICER - NeuBase Therapeutics, Inc.ex32-2.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - NeuBase Therapeutics, Inc.ex31-1.htm
EX-10.8(B) - AMENDMENT TO 2014 STOCK INCENTIVE PLAN - NeuBase Therapeutics, Inc.ex10-8b.htm
EX-10.2(E) - LOCK-UP AGREEMENT - NeuBase Therapeutics, Inc.ex10-2e.htm
EX-10.2(D) - RESTRICTED STOCK AGREEMENT - NeuBase Therapeutics, Inc.ex10-2d.htm
EX-10.2(C) - CONSULTING AGREEMENT AND RELEASE - NeuBase Therapeutics, Inc.ex10-2c.htm
EX-10.3(C) - PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT - NeuBase Therapeutics, Inc.ex10-3c.htm
10-K - ANNUAL REPORT - NeuBase Therapeutics, Inc.ohrp-10k_093015.htm
EX-10.2(F) - PROPRIETARY INFORMATION AND INVENTIONS AGREEMENT - NeuBase Therapeutics, Inc.ex10-2f.htm

 

Ohr Pharmaceutical, Inc. 10-K

 

Exhibit 23

 

Consent of Independent Registered Public Accounting Firm

 

Ohr Pharmaceutical, Inc.

New York, New York

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-201368) of Ohr Pharmaceutical, Inc. of our report dated December 14, 2015, relating to the consolidated financial statements, which appears in this Form 10-K.

 

/s/ MaloneBailey, LLP  
www.malone-bailey.com  
Houston, Texas  
December 14, 2015  

 

 

 

NeuBase Therapeutics, Inc. Reports